Law360, New York (November 30, 2012, 2:27 PM EST) -- The U.S. Food and Drug Administration has the cosmetics industry in its sights. Since September 2012, FDA has issued at least seven warning letters targeting the labeling and marketing of cosmetic products. And FDA has focused on companies at both ends of the spectrum — boutique houses with a handful of products and heavy hitters like Lancôme USA and Avon Products Inc.
In all of the letters, the FDA found fault with marketing claims that suggest the product has properties that are "intended to affect the structure or any function of the human body." The FDA explained that these structure/function claims...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!